ID26951A - Vaksin mycoplasma hyopneumontae recombinan - Google Patents

Vaksin mycoplasma hyopneumontae recombinan

Info

Publication number
ID26951A
ID26951A IDW20001242A ID20001242A ID26951A ID 26951 A ID26951 A ID 26951A ID W20001242 A IDW20001242 A ID W20001242A ID 20001242 A ID20001242 A ID 20001242A ID 26951 A ID26951 A ID 26951A
Authority
ID
Indonesia
Prior art keywords
hyopneumontae
mycoplasma
recombinant vaccine
vaccine
recombinant
Prior art date
Application number
IDW20001242A
Other languages
English (en)
Inventor
Chris F Minion
Hsu Tsungda
Original Assignee
Univ Iowa State Res Found Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Iowa State Res Found Inc filed Critical Univ Iowa State Res Found Inc
Publication of ID26951A publication Critical patent/ID26951A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IDW20001242A 1997-11-26 1998-11-24 Vaksin mycoplasma hyopneumontae recombinan ID26951A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6656597P 1997-11-26 1997-11-26

Publications (1)

Publication Number Publication Date
ID26951A true ID26951A (id) 2001-02-22

Family

ID=22070298

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001242A ID26951A (id) 1997-11-26 1998-11-24 Vaksin mycoplasma hyopneumontae recombinan

Country Status (13)

Country Link
US (1) US6162435A (id)
EP (1) EP1034004A1 (id)
JP (1) JP2001523481A (id)
KR (1) KR20010032493A (id)
CN (1) CN1301180A (id)
AU (1) AU1535299A (id)
BR (1) BR9815321A (id)
CA (1) CA2311759A1 (id)
HU (1) HUP0100130A2 (id)
ID (1) ID26951A (id)
PL (1) PL341797A1 (id)
WO (1) WO1999026664A1 (id)
ZA (1) ZA9810774B (id)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003003941A2 (en) 2001-07-02 2003-01-16 Pfizer Products Inc. One dose vaccination with mycoplasma hyopneumoniae
EP1546357B1 (en) * 2002-06-28 2013-08-07 Iowa State University Research Foundation, Inc. Immunogenic mycoplasma hyopneumoniae polypeptides
HUE028877T2 (en) * 2010-08-27 2017-01-30 Intervet Int Bv Test of biological activity of vaccine formulation
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
KR101503907B1 (ko) * 2013-01-17 2015-03-20 서울대학교산학협력단 흉막폐렴균과 마이코플라즈마 하이오뉴모니아 감염 질환 예방을 위한 재조합 단백질 백신
EP3049106A1 (en) 2013-09-25 2016-08-03 Zoetis Services LLC Pcv2b divergent vaccine composition and methods of use
CN108623663B (zh) * 2018-05-14 2021-09-21 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 猪肺炎支原体p97蛋白的免疫原性功能多肽及其编码基因和应用
US20250332242A1 (en) 2024-04-30 2025-10-30 Zoetis Services Llc Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use
US20250332243A1 (en) 2024-04-30 2025-10-30 Zoetis Services Llc Methods of manufacturing porcine endogenous retrovirus (perv) free animal health vaccines

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170646A (en) * 1978-07-17 1979-10-09 American Cyanamid Company Method for the control of Mycoplasma hyopneumoniae in swine with alkylated BM123γ type antibiotics
FR2578859B1 (fr) * 1985-03-12 1989-09-08 Commissariat Energie Atomique Appareillage et installation de realisation d'un depot metallique electrolytique d'epaisseur constante.
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US5252328A (en) * 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
US5240706A (en) * 1989-04-07 1993-08-31 Ml Technology Ventures, L.P. Intranasal administration of Mycoplasma hyopneumoniae antigen
JPH05506984A (ja) * 1990-04-02 1993-10-14 サイナーゲン，インコーポレーテッド 動物におけるマイコプラズマ感染に対する診断と治療に有用なポリペプチド
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5712090A (en) * 1993-05-18 1998-01-27 Iowa State University Research Foundation, Inc. PCR-based assay for Mycoplasma hyopneumoniae
US5788962A (en) * 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures

Also Published As

Publication number Publication date
BR9815321A (pt) 2002-01-02
WO1999026664A1 (en) 1999-06-03
AU1535299A (en) 1999-06-15
JP2001523481A (ja) 2001-11-27
HUP0100130A2 (hu) 2001-05-28
CN1301180A (zh) 2001-06-27
CA2311759A1 (en) 1999-06-03
PL341797A1 (en) 2001-05-07
ZA9810774B (en) 1999-05-26
KR20010032493A (ko) 2001-04-25
EP1034004A1 (en) 2000-09-13
US6162435A (en) 2000-12-19

Similar Documents

Publication Publication Date Title
NO2010013I2 (no) Rekombinant FSH-CTP
ATE275631T1 (de) Rekombinanter venezolanische-equine- pferdeenzephalitis-virusimpstoff
NO20003303D0 (no) Vaksine
BR9711853A (pt) Vacinas
DK0870508T3 (da) Influenzavaccine
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
IS5375A (is) KAY-nýstárlegt ónæmisprótín
ATE235920T1 (de) Interferon-konjugate
NO983141L (no) Antigene peptider
EP0998233A4 (en) PULMONARY BUBBLE REDUCING DEVICE
ID22933A (id) Fomulasi protien c terakivasi
NO20006191D0 (no) Vaksine
ATE189480T1 (de) Rekombinantes avipoxvirus
NO976058L (no) Rekombinant mistellectin
ID26951A (id) Vaksin mycoplasma hyopneumontae recombinan
IT1291135B1 (it) Vettori ricombinanti utilizzabili in terapia genica
EP1180999A4 (en) RECOMBINANT VACCINE AGAINST BOTULINUM NEUROTOXIN
FI933495L (fi) Rekombinantadenovirusvacciner
FI943626L (fi) Rekombinanttiadenovirusrokotteita
FI972325L (fi) Rekombinaattikonstruktio geeniekspression lisäämiseksi kasveissa
NO20005599D0 (no) Vaksine
ATE519775T1 (de) Rekombinante untereinheiten-impfstoffe
DE69527721D1 (de) Emitter-geschalteter thyristor
FR11C0050I2 (fr) Virus myxomateux recombinant
ATA63097A (de) Stuhl